Published on: May 2022
The evolution of the Breast Cancer Screening market overtime
Over the forecast period, the breast cancer screening test market is expected to grow at a CAGR of 4.5 percent. The rising knowledge regarding early detection of breast cancer, the rising incidence of breast cancer, and the expanding government initiatives and support are all contributing to the market's rise. The demand for breast cancer screening tests is increasing as the need for these tests grows in both developing and developed countries, resulting in market expansion.
Market Trends to Watch for Breast Cancer Screening
The Breast Cancer Screening Test Segment is Expected to Be Dominated by Imaging Tests. The imaging test is the most often used screening test for breast cancer, and these imaging tests are also the most trustworthy. Mammograms are the most often used screening diagnostics for breast cancer. Because mammography is the gold standard procedure for detecting breast cancer, governments and other healthcare organisations around the world are working to make mammography screening available to women aged 50 to 75. This is driving up demand for mammography around the world, while laboratory and blood testing, as well as other imaging tests, are becoming more popular. Digital breast tomosynthesis is used to examine equivocal or worrisome mammography data and can improve the diagnostic accuracy of mammography. In the diagnosis, staging, and follow-up of breast cancer, other modalities such as ultrasonography and contrast-enhanced magnetic resonance imaging (MRI) play an essential role.
Competitive Environment for Breast Cancer Screening market
The market for breast cancer screening tests is moderately competitive, with a number of large competitors. In terms of market share, the market is currently dominated by a few significant competitors. With rising public awareness and technological advancements in screening tests, a few more smaller competitors are projected to enter the market and gain a significant share. Allengers, Biocrates Life Sciences AG, Myriad Genetics, Hologic Inc., and Siemens Healthineers are among the market's key players.
Explore more Industry Data Analytics in our expert corner! contact@industrydataanalytics.com